Recruiting Triple Negative Breast Cancer Studies in Los Angeles
About Triple Negative Breast Cancer Clinical Trials in Los Angeles
Triple-negative breast cancer (TNBC) lacks estrogen receptors, progesterone receptors, and excess HER2 protein, limiting targeted treatment options. It accounts for about 10-15% of breast cancers and tends to be more aggressive. Active research focuses on immunotherapy and novel drug combinations.
There are currently 7 triple negative breast cancer clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 3,437 participants. Research is being sponsored by Gilead Sciences, Merck Sharp & Dohme LLC, Bristol-Myers Squibb and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Triple Negative Breast Cancer Clinical Trials in Los Angeles — FAQ
Are there triple negative breast cancer clinical trials in Los Angeles?
Yes, there are 7 triple negative breast cancer clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What triple negative breast cancer treatments are being tested?
The 7 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for triple negative breast cancer.
Data updated October 19, 2026 from ClinicalTrials.gov